EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein

Samuel Kyobe iD, Savannah Mwesigwa, Gyaviira Nkurunungi iD, Gaone Retshabile iD, Moses Egesa iD, Eric Katagirya iD, Marion Amujal iD, Busisiwe C Mlotshwa, Lesedi Williams, Hakim Sendagire, On Behalf Of The CAfGEN Consortium, Dithan Kiragga und 5 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Samuel Kyobe und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda. Hauptthemen laut MEDLINE: gag Gene Products, Human Immunodeficiency Virus, Epitopes, T-Lymphocyte, HLA-C Antigens, HIV-1. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIAID NIH HHS, Makerere University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efforts towards an effective HIV-1 vaccine have remained mainly unsuccessful. There is increasing evidence for a potential role of HLA-C-restricted CD8+ T cell responses in HIV-1 control, including our recent report of HLA-C*03:02 among African children. However, there are no documented optimal HIV-1 CD8+ T cell epitopes restricted by HLA-C*03:02; additionally, the structural influence of HLA-C*03:02 on epitope binding is undetermined. Immunoinformatics approaches provide a fast and inexpensive method to discover HLA-restricted epitopes. Here, we employed immunopeptidomics to identify HLA-C*03:02 CD8+ T cell epitopes. We identified a clade-specific Gag-derived GY9 (GTEELRSLY) HIV-1 p17 matrix epitope potentially restricted to HLA-C*03:02. Residues E62, T142, and E151 in the HLA-C*03:02 binding groove and positions p3, p6, and p9 on the GY9 epitope are crucial in shaping and stabilizing the epitope binding. Our findings support the growing evidence of the contribution of HLA-C molecules to HIV-1 control and provide a prospect for vaccine strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

gag Gene Products, Human Immunodeficiency VirusEpitopes, T-LymphocyteHLA-C AntigensHIV-1HumansT-Lymphocytes, CytotoxicAmino Acid SequenceProtein BindingHIV InfectionsHIV Antigens

Stichwörter der Autor:innen

HIV controlHLA-C*03:02immunoinformatics

Substanzen

gag Gene Products, Human Immunodeficiency VirusEpitopes, T-LymphocyteHLA-C Antigensp17 protein, Human Immunodeficiency Virus Type 1HIV Antigens

Autor:innen und Institutionen

  • Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.
  • Department of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala P.O. Box 7072, Uganda.
  • The Medical Research Council/Uganda Virus Research Institute & London School Hygine Tropical Medicine Uganda Research Unit, Entebbe P.O. Box 49, Uganda.
  • Department of Infection Biology, London School of Hygiene & Tropical Medicine, Keppel Street London, London WC1E 7HT, UK.
  • Department of Biological Sciences, University of Botswana, Gaborone Private Bag UB 0022, Botswana.
  • Baylor College of Medicine Children's Foundation, Kampala P.O. Box 72052, Uganda.

ORCID-Profile: Samuel Kyobe, Gyaviira Nkurunungi, Gaone Retshabile, Moses Egesa, Eric Katagirya, Marion Amujal, Jacqueline Kyosiimire-Lugemwa, David Robinson

Förderung

  • Wellcome Trust
  • NIAID NIH HHS
  • Makerere University
  • NIH Common Fund H3Africa Initiative
  • Makerere University-Uganda Virus Research Institute Centre of Excellence for Infection and Immunity Research and Training (MUII)
  • Makerere University Research and Innovations Fund
  • Africa Foundation to the Developing Excellence in Leadership
  • DELTAS Africa

Zitieren

APA

Kyobe, S., Mwesigwa, S., Nkurunungi, G., Retshabile, G., Egesa, M., Katagirya, E., Amujal, M., Mlotshwa, B. C., Williams, L., Sendagire, H., On Behalf Of The CAfGEN Consortium, Kiragga, D., Mardon, G., Matshaba, M., Hanchard, N. A., Kyosiimire-Lugemwa, J., & Robinson, D. (2024). Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179683

Vancouver

Kyobe S, Mwesigwa S, Nkurunungi G, Retshabile G, Egesa M, Katagirya E, et al. Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179683

BibTeX
@article{Kyobe2024,
  author = {Kyobe, Samuel and Mwesigwa, Savannah and Nkurunungi, Gyaviira and Retshabile, Gaone and Egesa, Moses and Katagirya, Eric and Amujal, Marion and Mlotshwa, Busisiwe C and Williams, Lesedi and Sendagire, Hakim and On Behalf Of The CAfGEN Consortium and Kiragga, Dithan and Mardon, Graeme and Matshaba, Mogomotsi and Hanchard, Neil A and Kyosiimire-Lugemwa, Jacqueline and Robinson, David},
  title = {Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179683}
}
Kostenlos starten →